Could antidepressant combat lethal lung cancer? - Houston weather, traffic, news | FOX 26 | MyFoxHouston

Could antidepressant combat lethal lung cancer?

Updated: Sep 27, 2013 09:22 AM
© CDC / Dr. Thomas Hooten © CDC / Dr. Thomas Hooten
  • Melissa's HealthworksMore>>

  • How to reduce those food allergies

    How to reduce those food allergies

    Monday, July 14 2014 4:28 PM EDT2014-07-14 20:28:55 GMT
    Ask the DoctorAsk the Doctor
    The number of allergies is skyrocketing. Some reports show as many as one-in-five Americans is allergic to something, including different types of food. The important question is: Is there anyway to reduce this obnoxious and potentially life-changing problem?
    The number of allergies is skyrocketing. Some reports show as many as one-in-five Americans is allergic to something, including different types of food. The important question is: Is there anyway to reduce this obnoxious and potentially life-changing problem?
  • A surprising health boost

    A surprising health boost

    Monday, July 14 2014 2:56 PM EDT2014-07-14 18:56:08 GMT
    Doctors often say your "gut" is the gateway to health. If it's healthy, chances are you are healthy. That's why it's important to know about a condition called "leaky gut" that can cause all kinds of issues.
    Doctors often say your "gut" is the gateway to health. If it's healthy, chances are you are healthy. That's why it's important to know about a condition called "leaky gut" that can cause all kinds of issues.
  • Eating fish can help prevent a stroke

    Eating fish can help prevent a stroke

    Monday, July 7 2014 3:00 PM EDT2014-07-07 19:00:50 GMT
    Stroke is the fourth leading cause of death in the U.S. and a leading cause of adult disability, but doctors want you to know that 80 percent of strokes can be prevented! Cardiologist Dr. John Higgins, from U.T. Memorial Hermann and Harris Health, shares some ways to prevent this top killer.
    Stroke is the fourth leading cause of death in the U.S. and a leading cause of adult disability, but doctors want you to know that 80 percent of strokes can be prevented! Cardiologist Dr. John Higgins, from U.T. Memorial Hermann and Harris Health, shares some ways to prevent this top killer.

FRIDAY, Sept. 27 (HealthDay News) -- An older and little-used class of antidepressants may help combat a particularly deadly form of lung cancer, according to a new study.

Using a unique computer program, researchers from the Stanford University School of Medicine identified tricyclic antidepressants as a potential treatment for small cell lung cancer. This class of drugs was introduced decades ago and is still approved for use in the United States, but has been supplanted by newer antidepressants with fewer side effects.

Follow-up experiments showed that the tricyclic antidepressant called imipramine (Tofranil), was effective against human small cell lung cancer cells grown in the laboratory and growing as tumors in mice. The drug activated a self-destruction pathway in the cancer cells and slowed or blocked the spread of cancer in mice.

Imipramine maintained its effectiveness regardless of whether the cancer cells had previously been exposed, and become resistant, to traditional chemotherapy treatments, according to the study, which was published online Sept. 27 in the journal Cancer Discovery.

Because tricyclic antidepressants already have U.S. Food and Drug Administration approval for use in people, the Stanford team was quickly able to launch a clinical trial to test imipramine in patients with small cell lung cancer and certain other types of cancer. They are currently recruiting patients for the phase-2 trial.

"We are cutting down the decade or more and the $1 billion it can typically take to translate a laboratory finding into a successful drug treatment to about one to two years and spending about $100,000," study co-senior author Dr. Atul Butte, director of the Center for Pediatric Bioinformatics at Lucile Packard Children's Hospital at Stanford, said in a university news release.

"The five-year survival for small cell lung cancer is only 5 percent," study co-senior author Julien Sage, an associate professor of pediatrics, said in the news release. "There has not been a single efficient therapy developed in the last 30 years. But when we began to test these drugs in human cancer cells grown in a dish and in a mouse model, they worked, and they worked, and they worked."

Another drug, an antihistamine called promethazine (Phenergan), also exhibited the ability to kill cancer cells, according to the researchers.

More information

The U.S. National Cancer Institute has more about small cell lung cancer.

Copyright © 2013 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow

KRIV FOX 26
4261 Southwest Freeway
Houston, TX 77027

Phone: (713) 479-2801
Fax: (713) 479-2859

Didn't find what you were looking for?
All content © Copyright 2000 - 2014 Fox Television Stations, Inc. and Worldnow. All Rights Reserved.
Privacy Policy | Terms of Service | Ad Choices